SAFE-iPS - France's First Hospital-based Platform for the Production of Induced Pluripotent Stem Cells for the Regenerative Medicine of the Future

NCT07735559 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Regenerative Medicine
Induced Pluripotent Stem Cells (iPSC) Production

Interventions

PROCEDURE: Blood Collection for iPSC Generation

Sponsor

University Hospital, Montpellier